Barely Significant
← all excerpts

Immunomodulatory Effects of a New Ethynylpiperidine Derivative: Enhancement of CD4<sup>+</sup>FoxP3<sup>+</sup> Regulatory T Cells in Experimental Acute Lung Injury.

Biomedicines · 2025 · PMC12730231 · PMID 41463029

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

a notable trendno p-value reported
22.2%; p = 0.045), and by day 14 a notable trend toward the recovery of CD4 + cell levels were noted—the value reached about 89% of the control and no statistical difference was found between these groups.

also in 2,162 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.